课题基金 / 基金详情

ASYMMETRIC SYNTHESIS OF IONOPHORE & MACROLIDE ANTIBIOTIC

ASYMMETRIC SYNTHESIS OF IONOPHORE & MACROLIDE ANTIBIOTIC
离子载体的不对称合成
批准号:
3282904
负责人:
David A Evans
金额:
$28.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-08-01 至 1995-11-30

项目摘要

项目成果

David A Evans的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objectives of this proposed research are to make creative contributions to the total synthesis of naturally occurring substances possessing clinically significant biological activity. The present grant will continue to address the development of new stereoselective reactions and the application of this methodology to the asymmetric synthesis of ionophore and macrolide antibiotics and antineoplastic agents. The methodological studies dealing with new reaction discovery will emphasize the development of new reactions for controlling the stereochemical course of chemical processes. In the present study we will continue to focus our attention on "directable" chemical processes. These studies will focus on the continued development of an iridium-catalyzed directable hydroboration process, the development of a directable Meerwein-Ponndorff-Verley reduction based on samarium diiodide, and the application of intramolecular variants of the Tishchenko reaction for long-range directed reductions of ketones. The targets for total synthesis will include the development of asymmetric syntheses of the antineoplastic agents bryostatin, calyculin, macbecin, and herbimycin, the ionophore antibiotic lonomycin, and the oligomycin macrolide rutamycin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Community Outreach & Education
Synthesis of Polyketides and Terpenes
  • 批准号:
    7460700
  • 项目类别:
  • 资助金额:
    $40.66万
  • 财政年份:
    2007
  • 负责人:
    David A Evans
  • 依托单位:
Synthesis of Polyketides and Terpenes
  • 批准号:
    7625089
  • 项目类别:
  • 资助金额:
    $41.84万
  • 财政年份:
    2007
  • 负责人:
    David A Evans
  • 依托单位:
Synthesis of Polyketides and Terpenes
  • 批准号:
    7300781
  • 项目类别:
  • 资助金额:
    $40.93万
  • 财政年份:
    2007
  • 负责人:
    David A Evans
  • 依托单位: